Esperion Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 34 U.S.-traded ETFs. ESPR has around 2.9M shares in the U.S. ETF market. The largest ETF holder of ESPR is the SPDR S&P Biotech ETF (XBI), with approximately 1.22M shares. Investors may also find of interest that the ETF with the largest allocation to ESPR stock is Virtus LifeSci Biotech Products ETF (BBP), with a portfolio weight of 2.37%. On average, U.S. ETFs allocate 0.22% of ESPR to their portfolios.
Additionally, ESPR is a favorite stock for Vanilla and Equal ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with ESPR as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 39.80%.